The firm also named Lori M. Henderson vice president, general counsel and secretary...Anadys Pharmaceuticals Inc., of San Diego, named Kevin L. Eastwood senior vice president of corporate development, promoted James Appleman to senior vice president of research and chief scientific officer, appointed James L. Freddo to the board and named Stelios Papadopoulos chairman...AspenBio Pharma Inc., of Castle Rock, Colo., added Erik S. Miller as vice president of marketing and business development

Receptos Inc., of San Diego, appointed Faheem Hasnain president, CEO and board member...Selvita, of Krakow Poland, appointed Piotr Prelich vice president of sales and marketing...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Bob Radie president and CEO

and added Tamara A. Seymour as chief financial officer...Hybrigenics, of Paris, named William Vickery head of corporate and business development...Medistem Inc., of San Diego, appointed Vladimir Bogin president and chairman

Celtaxys Inc., of Atlanta, named Michael Hanley CEO and chairman...Codexis Inc., Redwood City, Calif., named William Rothwell vice president and general manager of Biobased Chemicals...Cytomedix Inc., of Gaithersburg, Md., formed a scientific advisory board with the appointments of Marissa Carter, Jean de Leon, Vickie R. Driver, Peter A. M. Everts, Will W. Li and Thomas E. Serena

plc, of Dublin, Ireland, appointed Kristine Peterson to its board and named Joseph S. Zakrzewski CEO...Ambit Biosciences Corp., of San Diego, named Faheem Hasnain chairman and appointed Alan Fuhrman chief financial officer...AnaptysBio Inc., of San Diego, named Jan de Vries, Nicholas B. Lydon and Phillip A. Patten to its scientific and therapeutic advisory boards

Roche, of Nutley, N.J., named Jacques Banchereau senior vice president and head of the inflammation and virology discovery and translational areas

Neovacs, of Paris, appointed Florence Hocdee-Leroy communications and investor relations director...Oligomerix Inc., of New York, appointed Vic Micati chairman and named Jack Pasini chief commercial officer and board member

Accera Inc., of Broomfield, Colo., appointed Thomas Werner president and CEO...Agile Therapeutics Inc., of Princeton, N.J., named Al Altomari president and CEO...AIKO Biotechnology, of Portland, Maine, appointed Jim New CEO and added Paul Goldenheim to its board

HemoShear LLC, of Charlottesville, Va., added Robert Ruffolo and Kenneth Batchelor to its scientific advisory board...Horizon Discovery Ltd., of Cambridge, UK, appointed Nigel Pitchford and David Evans to its board...NeoStem Inc., of New York, appointed Ian Zhang president and managing director of NeoStem (China) Inc

BioMarin Pharmaceutical Inc., of Novato, Calif., appointed William D. Young and Kenneth M. Bate to its board...Celgene Corp., of Summit, N.J., appointed Jacqualyn A. Fouse senior vice president and chief financial officer...Cubist Pharmaceuticals Inc., of Lexington, Mass., promoted Steven C. Gilman to executive vice president of R&D and chief scientific officer

Aegerion Pharmaceuticals Inc., of Bridgewater, N.J., named Marc Beer CEO and board member...Aquinox Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Csaba Szabo vice president of research and chief scientific officer...AVEO Pharmaceuticals Inc., of Cambridge, Mass., appointed Michael P. Bailey chief commercial officer and Donna M. Radzik vice president of technical operations

in Europe, Asia and Latin America...He previously served as executive vice president of Abbott Corp., of Abbott Park, Ill., and president of its pharmaceutics division, in addtion to group president for Europe and subsequently president of Abbott International

Celsion Corp., of Columbia, Md., appointed Sid Taubenfeld director of communications and strategic initiatives and named Robert W. Hooper to its board...Dynavax Technologies Corp., of Berkeley, Calif., promoted J. Tyler Martin to president and appointed him to the board

The firm also appointed Ronald Evans and David Mangelsdorf to its scientific advisory board

plc, of Dublin, Ireland, appointed Colin W. Stewart president, CEO and a member of the company's board, effective Aug. 16...Selecta Biosciences Inc., of Watertown, Mass., appointed Werner Cautreels president and CEO...Cautreels most recently served as CEO and global head of R&D at Solvay Pharmaceuticals Inc., acquired earlier this year by Abbott, of Abbott Park, Ill. (See BioWorld Today, Sept. 29, 2009

Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Julie A. Caudill vice president of finance and corporate controller...Ambit Biosciences Corp., of San Diego, appointed Alan J. Lewis chairman and CEO...Lewis, who most recently served as president and CEO of the Juvenile Diabetes Research Foundation, has been serving as Ambit's executive chairman since March

The Foundation for the National Institutes of Health appointed Scott Campbell director and CEO...Taris Biomedical Inc., of Lexington, Mass., appointed Sarma Duddu president, CEO and a member of its board...Most recently, Duddu was general manager and vice president of worldwide drug delivery technologies at CIMA Labs Inc, a wholly owned subsidiary of Cephalon Inc., of Frazer, Pa

Probiodrug AG, of Halle, Germany, appointed Claus Braestrup chairman and named Lennart Mucke to its scientific advisory board...Spencer Pharmaceutical Inc., of Boston, named Max Arella president and chairman...YM BioSciences Inc., of Mississauga, Ontario, appointed Nick Glover president and chief operating officer

Novavax Inc., of Rockville, Md., appointed John W. Madsen head of process and manufacturing operations and named Steven Pincus head of analytical and quality operations...Probiodrug AG, of Halle, Germany, appointed Claus Braestrup chairman and named Lennart Mucke to its scientific advisory board